active: true
address:
    address1: 3 MORE LONDON RIVERSIDE
    city: LONDON
    postal_code: SE1 2RE
    state: X0
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/dmVyb25hcGhhcm1hLmNvbQ/images/2025-04-04_icon.png
    logo_url: https://api.polygon.io/v1/reference/company-branding/dmVyb25hcGhhcm1hLmNvbQ/images/2025-04-04_logo.svg
cik: '0001657312'
composite_figi: BBG00GD4KBL1
currency_name: usd
description: Verona Pharma PLC is a clinical-stage biopharmaceutical company focused
    on developing and commercializing therapeutics for the treatment of respiratory
    diseases with unmet medical needs. The company is currently focusing on developing
    its Ensifentrine product candidate, which will treat chronic obstructive pulmonary
    disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including
    asthma.
homepage_url: https://www.veronapharma.com
list_date: '2017-04-27'
locale: us
market: stocks
market_cap: 9067411129.2
name: Verona Pharma plc
phone_number: 011-44-0-2032834200
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG00GD4KBM0
share_class_shares_outstanding: 85132003
sic_code: '2834'
sic_description: PHARMACEUTICAL PREPARATIONS
ticker: VRNA
ticker_root: VRNA
total_employees: 209
type: ADRC
weighted_shares_outstanding: 86192121
